ABUS
vs
U
USBC
ABUS
Over the past 12 months, ABUS has underperformed USBC, delivering a return of +20% compared to the USBC's +598 500% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ABUS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
4.105
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.5986
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ABUS, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Arbutus Biopharma Corp
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ABUS, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ABUS, USBC
Performance By Year
ABUS, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.